SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+4.36%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$912M
AUM Growth
+$912M
(+14%)
Cap. Flow
+$98.3M
Cap. Flow
% of AUM
10.78%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
80
New
13
Increased
28
Reduced
21
Closed
12
Top Buys
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$16.8M |
| 2 |
Gilead Sciences
GILD
|
$15.5M |
| 3 |
Exact Sciences
EXAS
|
$15.4M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$12.5M |
| 5 |
Cogent Biosciences
COGT
|
$12M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$19.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$14.8M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$12.8M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$12.3M |
| 5 |
AbbVie
ABBV
|
$8.25M |
Sector Composition
| 1 | Healthcare | 91.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
26
DELISTED
TESARO, Inc.
TSRO
| $12.9M | 1.41% |
225,260
+188,660
| +515% | +$10.8M |
|
|
PRAH
27
DELISTED
PRA Health Sciences, Inc.
PRAH
| $12.5M | 1.37% |
+150,560
| New | +$12.5M |
|
|
28
Cogent Biosciences
COGT
$1.83B
| $12M | 1.32% |
+1,081,545
| New | +$12M |
|
29
PTC Therapeutics
PTCT
$4.41B
| $11.9M | 1.3% |
437,934
+65,300
| +18% | +$1.77M |
|
|
ALDR
30
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $11M | 1.2% |
+863,600
| New | +$11M |
|
|
ALXN
31
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $10.7M | 1.17% |
+96,000
| New | +$10.7M |
|
32
Nektar Therapeutics
NKTR
$543M
| $10.5M | 1.15% |
98,914
-18,901
| -16% | -$2.01M |
|
33
Glaukos
GKOS
$5.42B
| $10.1M | 1.11% |
+329,199
| New | +$10.1M |
|
34
Cigna
CI
$80.2B
| $9.94M | 1.09% |
59,237
-8,378
| -12% | -$1.41M |
|
35
iRhythm Technologies
IRTC
$5.67B
| $9.92M | 1.09% |
157,600
-37,200
| -19% | -$2.34M |
|
36
Bristol-Myers Squibb
BMY
$96.7B
| $9.69M | 1.06% |
+153,200
| New | +$9.69M |
|
37
Esperion Therapeutics
ESPR
$490M
| $9.58M | 1.05% |
132,468
+109,135
| +468% | +$7.89M |
|
38
Neurocrine Biosciences
NBIX
$13.5B
| $9.24M | 1.01% |
111,402
-30,900
| -22% | -$2.56M |
|
|
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $9.03M | 0.99% |
186,994
-254,774
| -58% | -$12.3M |
|
40
Molina Healthcare
MOH
$9.6B
| $8.77M | 0.96% |
108,070
+55,810
| +107% | +$4.53M |
|
|
XLRN
41
DELISTED
Acceleron Pharma Inc.
XLRN
| $8.77M | 0.96% |
224,226
-488,130
| -69% | -$19.1M |
|
|
NVRO
42
DELISTED
NEVRO CORP.
NVRO
| $8.44M | 0.93% |
+97,400
| New | +$8.44M |
|
|
ADMS
43
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $8.4M | 0.92% |
+351,320
| New | +$8.4M |
|
44
Insulet
PODD
$24.2B
| $8.19M | 0.9% |
94,509
| – | – |
|
|
HRC
45
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $7.67M | 0.84% |
88,200
+18,750
| +27% | +$1.63M |
|
|
VRAY
46
DELISTED
ViewRay, Inc.
VRAY
| $7.33M | 0.8% |
1,139,863
+192,557
| +20% | +$1.24M |
|
47
Vertex Pharmaceuticals
VRTX
$102B
| $6.83M | 0.75% |
41,915
+5,200
| +14% | +$847K |
|
48
Integra LifeSciences
IART
$1.18B
| $6.82M | 0.75% |
123,198
| – | – |
|
49
Incyte
INCY
$17B
| $6.6M | 0.72% |
79,245
+40,300
| +103% | +$3.36M |
|
50
Masimo
MASI
$7.43B
| $6.4M | 0.7% |
72,800
| – | – |
|